Jessica Garcia: Real-World Evidence on Efanesoctocog Alfa Prophylaxis in Pediatric Hemophilia A
Jessica Garcia, Pediatric Hematologist, Hemostasis and Thrombosis Specialist at UT Southwestern Medical Center, shared a post on LinkedIn about a recent article she and Ayesha Zia, published in Haemophilia, adding:
“I’m happy to share our latest publication in Haemophilia!
Our paper explores real-world clinical outcomes and thrombin generation in pediatric patients with hemophilia A receiving efanesoctocog Alfa.
I hope our findings add to the growing evidence supporting the optimization of prophylactic treatment and care for children living with hemophilia A.”
Title: Real-World Clinical Data and Thrombin Generation of Efanesoctocog Alfa Prophylaxis in Pediatric Patients With Haemophilia A
Authors: Jessica Garcia, Ayesha Zia
More posts featuring Jessica Garcia on Hemostasis Today.
-
Oct 31, 2026, 19:40Andreas Calatzis: Revisiting a Widely Cited Study on Preoperative Screening for Primary Hemostasis Disorders
-
Oct 31, 2026, 19:40How Antiseizure Medication Selection May Influence DOAC Safety in Epilepsy – JAMA Neurology
-
Oct 31, 2026, 19:35Alejandro González Veliz: Balancing Ischemic Protection and Bleeding Risk in Antiplatelet Management
-
Oct 31, 2026, 19:29Sascha David: Therapeutic Plasma Exchange Associated with Lower 90 Day Mortality in Streptococcal Septic Shock
-
Oct 31, 2026, 19:21Cedric Hermans: What If Higher Plasma FIX Levels Do Not Necessarily Mean better Haemostatic Protection?
-
Oct 31, 2026, 19:16Valance Washington: Celebrating Sravya Nimmala’s Outstanding Abstract Award
-
Oct 31, 2026, 16:41Ward Faisal: Ferric Carboxymaltose as an Alternative to Traditional Iron Preparations for Anemia
-
Oct 31, 2026, 16:35Bhavna Daryani: Using Technology to Make Anemia Screening More Accessible and Non-Invasive
-
Oct 31, 2026, 16:33Greg Jackson: Key Insights from the 22nd Annual McMaster Hematology and Thromboembolism Update